ValSource Senior Director of Consulting Dr. Michael Long Leads Parenteral Drug Association Applied Statistics Interest Group
September 15, 2015
ValSource announced, Senior Director of Consulting Mr. Michael Long to Lead the Parenteral Drug Association’s (“PDA”) new Applied Statistics Interest Group. The Applied Statistics Interest Group is concerned with the creation, development and manufacture of pharmaceutical products using statistical tools from starting materials to finished product. From development through manufacture and end of use, its focus encompasses the entire lifecycle. Its seeks to improve the understanding of issues for applied statistics within the scientific, technical and pharmaceutical community, while providing an environment where PDA membership has a resource to explore and understand tools being employed by experienced users….
ValSource Announces Geographic Regions Hyper Local Focus Provides National Coverage & Enables Rapid Deployment
June 26, 2015
ValSource announced, it has completed structure of seven national geographic regions. The company now maintains a dedicated presence in a regional footprint that includes the entire United States. ValSource employs more full time validation professionals than any other qualified resource in each of its seven regions. These hyper-localized hubs provide readily and easily mobilized talent and resources.
Southern Region – encompassing states and areas south of the Carolinas: Georgia, Alabama, Mississippi, Louisiana, Florida, and Puerto Rico….
June 17, 2015
ValSource announced, Amanda Bishop McFarland has joined North America’s largest independent validation services company as a consultant. Prior to ValSource, Amanda spent five years with Genzyme, most recently serving as Senior Continuous Process Improvement Analyst.
Amanda McFarland comments, “ValSource provides me the perfect opportunity to share my QRM and Microbiology knowledge to influence change in our industry.” Amanda specializes in quality risk management, program implementation and partnership development and contamination control.
Amanda McFarland earned both her Bachelor of Science in Entomology and her Master of Science in Mycology and Air Quality from the University of Florida….
May 27, 2015
ValSource announced Consultant Bob Wissert (“Bob”), is a speaker and panelist at the 2015 Ultrapure Water Pharma Annual Conference. The conference takes place, June 2nd-3rd at the Double Tree Hotel in Bethesda, Maryland. On June 2nd Bob is a panelist on the discussion of Life Cycle Approaches for Pharma Water Systems, examining issues that arise with aging pharmaceutical water systems. On June 3rd, he is presenting the update for the PDA Water Interest Group – Using Resources to Share and Learn in the Pharmaceutical
The 2015 UPW Pharma Conference aims to dispel the water treatment myths and to serve as a forum for educating delegates on new developments that impact the future of pharmaceutical water treatment. …
April 21, 2015
ValSource announced Jeffrey L. Hartman has joined North America’s largest independent validation services company as a Senior Validation and Quality Risk Management (“QRM”) Consultant. Prior to ValSource, Jeff Hartman spent 34 years with Merck, most recently serving as Director of Validation Quality Systems for Merck Manufacturing Division.
Considering his future with ValSource, Hartman commented, “Candidly, I’m past the point of having to work. I’m relishing working with such a great company. ValSource’s vision of returning validation to a vital, valuable tool for companies aligns perfectly with my own professional philosophy.” He continued, “I’m energized and look forward to the knowledge transfer process with ValSource’s clients….
Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride.
April 2, 2015
Kim, Ahn, LiPuma, Hussong, and Cerniglia. 2015. Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride. Journal of Industrial Microbiology & Biotechnology. Date: 21 Mar 2015 (online) http://link.springer.com/article/10.1007/s10295-015-1605-x
The Burkholderia cepacia complex (BCC) includes opportunistic pathogenic bacteria that have occasionally been recovered from various pharmaceutical products, including antiseptics and disinfectants. Plausible reasons for the contamination include intrinsic sources, such as inadequate process controls, especially for water or equipment used during product manufacture, or extrinsic sources, such as improper handling and dilution or distribution in contaminated containers….
March 9, 2015
ValSource announced David Hussong, Ph.D. has joined the company as Senior Microbiology and Regulatory Consultant. David Hussong has spent most of his entire career, more than 30 years, at the Food and Drug Administration. For the last decade he served as Supervisor of the New Drug Microbiology Staff in the Office of Pharmaceutical Science (“OPS”) and as the Associate Director for New Drug Microbiology, OPS – Center for Drug Evaluation and Research (“CDER”). There, his work encompassed significant policy and scientific influence in all matters of review of microbiology issues and products applications….
February 12, 2015
ValSource, LLC, today announced, after an extensive strategic branding exercise, the company recently underwent the first significant rebrand in its nearly 20-year history. The rebrand centers on the tagline and brand theme: Validation. Delivered. The rebrand was motivated by ValSource’s desire to distinguish its elite validation services and better reflect its singular focus on returning validation to a scientific event which helps companies design, perform and control better manufacturing processes throughout all stages of the operations life cycle.
The new brand essence and elements communicate ValSource’s elite validation solution, which addresses the continuum of all the related processes, delivers a sustainably reliable product and has a measurable value to better performance….